Adaptive Biotechnologies Corp vs Cincinnati Financial Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.05B), while Cincinnati Financial Corporation trades at $173.45 (market cap $26.68B). The key difference: Cincinnati Financial Corporation is far larger — about 6.6× Adaptive Biotechnologies Corp's market cap, and Cincinnati Financial Corporation pays a 2.16% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | CINF | |
|---|---|---|
Market Cap | $4.05B | $26.68B |
Sector | Health | Financials |
52-Week High | $25.45 | $192.03 |
52-Week Low | $12.30 | $149.79 |
Enterprise Value | $4.12B | $25.80B |
Dividend Yield | — | 2.16% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Read more on CINF →